论文信息 - Efficacy and safety of telaprevir (TVR) triple therapy in a ‘real‐life’ cohort of 102 patients with HCV genotype 1: interim analysis after 24 weeks of treatment - 字舞流文

Efficacy and safety of telaprevir (TVR) triple therapy in a ‘real‐life’ cohort of 102 patients with HCV genotype 1: interim analysis after 24 weeks of treatment

C. Berg | U. Lauer | N. Malek | C. Werner | C. Franz | D. Egetemeyr | P. Janke-Maier | U. Lauer | C. Werner | D. P. Egetemeyr | U. M. Lauer